Literature DB >> 30190990

Screening and treatment of hepatitis B virus to prevent liver cancer in Africa.

Mark R Thursz1.   

Abstract

Entities:  

Year:  2015        PMID： 30190990      PMCID： PMC6095328          DOI： 10.2217/hep.15.4

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN： 2045-0923


× No keyword cloud information.
  10 in total

Review 1.  EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Authors: 
Journal:  J Hepatol       Date:  2008-10-29       Impact factor: 25.083

Review 2.  Part I: Cancer in Indigenous Africans--burden, distribution, and trends.

Authors:  D Max Parkin; Freddy Sitas; Mike Chirenje; Lara Stein; Raymond Abratt; Henry Wabinga
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

3.  Heterozygote advantage for HLA class-II type in hepatitis B virus infection.

Authors:  M R Thursz; H C Thomas; B M Greenwood; A V Hill
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

4.  Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis.

Authors:  U Dumpis; E C Holmes; M Mendy; A Hill; M Thursz; A Hall; H Whittle; P Karayiannis
Journal:  J Hepatol       Date:  2001-07       Impact factor: 25.083

5.  Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.

Authors:  Mohamed I F Shariff; Nimzing G Ladep; I Jane Cox; Horace R T Williams; Edith Okeke; Abraham Malu; Andrew V Thillainayagam; Mary M E Crossey; Shahid A Khan; Howard C Thomas; Simon D Taylor-Robinson
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

6.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia.

Authors:  M R Thursz; D Kwiatkowski; C E Allsopp; B M Greenwood; H C Thomas; A V Hill
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

7.  Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Authors:  Yun-Fan Liaw; Joseph J Y Sung; Wan Cheng Chow; Geoffrey Farrell; Cha-Ze Lee; Hon Yuen; Tawesak Tanwandee; Qi-Min Tao; Kelly Shue; Oliver N Keene; Jonathan S Dixon; D Fraser Gray; Jan Sabbat
Journal:  N Engl J Med       Date:  2004-10-07       Impact factor: 91.245

8.  The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.

Authors:  Gregory D Kirk; Olufunmilayo A Lesi; Maimuna Mendy; Aliu O Akano; Omar Sam; James J Goedert; Pierre Hainaut; Andrew J Hall; Hilton Whittle; Ruggero Montesano
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

9.  Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence.

Authors:  Angela J Frodsham; Lyna Zhang; Uga Dumpis; Nor Azizah Mohd Taib; Steve Best; Andrew Durham; Branwen J W Hennig; Simon Hellier; Susanne Knapp; Mark Wright; Maria Chiaramonte; John I Bell; Mary Graves; Hilton C Whittle; Howard C Thomas; Mark R Thursz; Adrian V S Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

10.  Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.

Authors:  Nimzing G Ladep; Anthony C Dona; Matthew R Lewis; Mary M E Crossey; Maud Lemoine; Edith Okeke; Yusuke Shimakawa; Mary Duguru; Harr F Njai; Haddy K S Fye; Makie Taal; John Chetwood; Ben Kasstan; Shahid A Khan; Deborah A Garside; Anisha Wijeyesekera; Andrew V Thillainayagam; Edmund Banwat; Mark R Thursz; Jeremy K Nicholson; Ramou Njie; Elaine Holmes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.